Page 101 - Read Online

Li et al. Hepatoma Res 2020;6:39 I http://dx.doi.org/10.20517/2394-5079.2020.13 Page 7 of 7

hepatocellular carcinoma. J Gastroenterol Hepatol 2014;29:372-9.
14. Bae SH, Park HC, Lim DH, Lee JA, Gwak GY, et al. Salvage treatment with hypofractionated radiotherapy in patients with recurrent
small hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2012;82:e603-7.
15. Honda Y, Kimura T, Aikata H, Kobayashi T, Fukuhara T, et al. Stereotactic body radiation therapy combined with transcatheter arterial
chemoembolization for small hepatocellular carcinoma. J Gastroenterol Hepatol 2013;28:530-6.
16. Park JH, Yoon SM, Lim YS, Kim SY, Shim JH, et al. Two-week schedule of hypofractionated radiotherapy as a local salvage treatment
for small hepatocellular carcinoma. J Gastroenterol Hepatol 2013;28:1638-42.
17. Yuan Z, Tian L, Wang P, Song Y, Dong Y, et al. Comparative research on the efficacy of CyberKnife® and surgical excision for Stage I
hepatocellular carcinoma. Onco Targets Ther 2013;6:1527-32.
18. Choi BO, Choi IB, Jang HS, Kang YN, Jang JS, et al. Stereotactic body radiation therapy with or without transarterial chemoembolization
for patients with primary hepatocellular carcinoma: preliminary analysis. BMC Cancer 2008;8:351.
19. Xi M, Zhang L, Zhao L, Li QQ, Guo SP, et al. Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal
vein and/or inferior vena cava tumor thrombosis. PLoS One 2013;8:e63864.
20. Wu DH,Chen LH. Efficacy of 3 dimensional conformal hypofractionated single high dose radiotherapy combined with transcatheter
arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma. Chin J Cancer 2004;23:3.825s.
21. Tse RV, Hawkins M, Lockwood G, Kim JJ, Cummings B, et al. Phase I study of individualized stereotactic body radiotherapy for
hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol 2008;26:657-64.
22. Bujold A, Massey CA, Kim JJ, Brierley J, Cho C, et al. Sequential phase I and II trials of stereotactic body radiotherapy for locally
advanced hepatocellular carcinoma. J Clin Oncol 2013;31:1631-9.
23. Kamiyama T, Nakanishi K, Yokoo H, Tahara M, Nakagawa T, et al. Efficacy of preoperative radiotherapy to portal vein tumor thrombus
in the main trunk or first branch in patients with hepatocellular carcinoma. Int J Clin Oncol 2007;12:363-8.
24. Wei X, Jiang Y, Zhang X, Feng S, Zhou B, et al. Neoadjuvant three-dimensional conformal radiotherapy for resectable hepatocellular
carcinoma with portal vein tumor thrombus: a randomized, open-label, multicenter controlled study. J Clin Oncol 2019;37:2141-51.
25. Kim J, Lee I, Han K, Kim J, Kim K, et al. Clinical features of hepatocellular carcinoma patients undergoing resection after concurrent
chemoradiation therapy. Int J Radiat Oncol Biol Phys 2012;84:S336-7.
26. Katz AW, Chawla S, Qu Z, Kashyap R, Milano MT, et al. Stereotactic hypofractionated radiation therapy as a bridge to transplantation for
hepatocellular carcinoma: clinical outcome and pathologic correlation. Int J Radiat Oncol Biol Phys 2012;83:895-900.
27. O’Connor JK, Trotter J, Davis GL, Dempster J, Klintmalm GB, et al. Long-term outcomes of stereotactic body radiation therapy in the
treatment of hepatocellular cancer as a bridge to transplantation. Liver Transpl 2012;18:949-54.
28. Sapisochin G, Barry A, Doherty M, Fischer S, Goldaracena N, et al. Stereotactic body radiotherapy vs. TACE or RFA as a bridge to
transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis. J Hepatol 2017;67:92-9.
29. Wang WH, Wang Z, Wu JX, Zhang T, Rong WQ, et al. Survival benefit with IMRT following narrow-margin hepatectomy in patients
with hepatocellular carcinoma close to major vessels. Liver Int 2015;35:2603-10.
30. Rodríguez-Perálvarez M, Luong TV, Andreana L, Meyer T, Dhillon AP, et al. A systematic review of microvascular invasion in
hepatocellular carcinoma: diagnostic and prognostic variability. Ann Surg Oncol 2013;20:325-39.
31. Wang L, Wang W, Yao X, Rong W, Wu F, et al. Postoperative adjuvant radiotherapy is associated with improved survival in hepatocellular
carcinoma with microvascular invasion. Oncotarget 2017;8:79971-81.